Chemotherapy Hair Loss: Symptoms, Causes, Treatment

Scalp, eyebrow, eyelash and body hair can be affected, with emotional and self-image consequences. Growth usually returns, but timing and density vary and some people have persistent thinning.

Related reading: Neuropathy as another effect to report to the oncology team.

Hair may shed gradually or in clumps during the early treatment weeks, sometimes with scalp sensitivity. Regrowth can have a different texture or color; shedding does not measure anticancer success.

Drug type, dose and combinations determine follicle effects. Other contributors, including thyroid or nutritional problems, may also need consideration.

Risk depends on treatment type, dose, schedule, combined therapies and previous hair health. Scalp-cooling effectiveness varies and it is unsuitable for some cancers or medicines.

The team reviews timing, medicines and scalp findings. Unexpected patterns, inflammation or persistent loss beyond the expected recovery period may warrant dermatology assessment or tests.

Care includes gentle hair handling and support for personal choices about head coverings. Scalp cooling may suit selected solid-tumor regimens and should be discussed before treatment starts.

Irritation, sun sensitivity and psychological or social distress may occur. Regrowth can be delayed or incomplete; supportive and dermatological care can help.

No method guarantees prevention. Avoid traction, excessive heat and irritating chemicals and protect the scalp from sun and cold. Discuss minoxidil or supplements before starting them.